Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 Feb 20;162(5):1436–1448.e6. doi: 10.1016/j.jtcvs.2020.01.094

Table 1.

Demographics

Total
(n=175)
Pathogenic
(n=31)
Benign/Normal
(n=144)
p-value
Age at dissection (years) 55 (46, 65) 43 (30, 51) 56 (47, 66) <0.0001
Sex, male 112 (64) 14 (45) 98 (68) 0.02
Body mass index (kg/m2) 29 (25, 33) 27 (24, 30) 29 (25, 34) 0.09
Hypertension 109 (62) 8 (26) 101 (70) <0.0001
Dyslipidemia 50 (29) 3 (10) 47 (33) 0.01
Coronary artery disease 16 (9) 2 (7) 14 (10) 0.74
Smoking history 79 (45) 10 (32) 69 (48) 0.11
COPD 9 (5) 0 (0) 9 (6) 0.36
Diabetes 6 (3) 0 (0) 6 (4) 0.59
History of stroke 2 (1) 0 (0) 2 (1) 1.00
Chronic kidney disease 6 (3) 0 (0) 6 (4) 0.59
Peripheral arterial disease 2 (1) 0 (0) 2 (1) 1.00
Prior cardiac surgery 16 (9) 6 (19) 10 (7) 0.04
 Root replacement 8 (5) 5 (16) 3 (2) 0.005
Aortic aneurysm
 Root 61 (35) 17 (55) 44 (31) 0.01
 Ascending 78 (45) 14 (45) 64 (44) 0.94
 Arch 32 (18) 4 (13) 28 (19) 0.39
 Descending 54 (31) 7 (23) 47 (33) 0.27
Aortic dissection
 Type A 108 (62) 21 (68) 87 (60) 0.45
 Type B 67 (38) 10 (32) 57 (40) 0.45
Condition at time of dissection
 Acute stroke 4 (2) 2 (7) 2 (1) 0.15
 Acute myocardia infarction 2 (1) 1 (3) 1 (1) 0.32
 Acute renal failure 6 (3) 1 (3) 5 (4) 1.00
 Acute paralysis 0 (0) 0 (0) 0 (0) -
Medications at time of dissection
 Beta blocker 46 (26) 6 (19) 40 (28) 0.33
 ACE inhibitor 23 (13) 3 (10) 20 (14) 0.77
 Calcium channel blocker 15 (9) 0 (0) 15 (10) 0.08
 Angiotensin II receptor blocker 6 (3) 0 (0) 6 (4) 0.59

Data presented as median (25%, 75%) for continuous data and n (%) for categorical data.

ACE = angiotensin converting enzyme; COPD=chronic obstructive pulmonary disease